Metraipolis › archive › dc_29d43d700fcd

Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40658469
DOI
10.1093/oncolo/oyaf210
License (as archived)
solo-consultazione
Archived
2026-11-10T04:39:03.287Z
SHA-256 of the archived text
4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375
Stable URL of this page
https://metraipolis.com/documento/dc_29d43d700fcd

How to cite

Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469 — Europe PMC (en), https://europepmc.org/article/MED/40658469 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29d43d700fcd (Metraipolis archive dc_29d43d700fcd, sha256 4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375)
BibTeX
@misc{dc29d43d700fcd,
  title = {Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40658469},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29d43d700fcd; sha256 4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40658469. Agents can read the archived copy with the MCP tool read_document.